These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25308708)
1. Production and purification of plasmid DNA vaccines: is there scope for further innovation? Xenopoulos A; Pattnaik P Expert Rev Vaccines; 2014 Dec; 13(12):1537-51. PubMed ID: 25308708 [TBL] [Abstract][Full Text] [Related]
3. Upstream processing of plasmid DNA for vaccine and gene therapy applications. Tejeda-Mansir A; Montesinos RM Recent Pat Biotechnol; 2008; 2(3):156-72. PubMed ID: 19075863 [TBL] [Abstract][Full Text] [Related]
4. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications. Sousa A; Tomaz CT; Sousa F; Queiroz JA J Chromatogr A; 2011 Nov; 1218(46):8333-43. PubMed ID: 21995857 [TBL] [Abstract][Full Text] [Related]
5. Plasmid fermentation process for DNA immunization applications. Carnes AE; Williams JA Methods Mol Biol; 2014; 1143():197-217. PubMed ID: 24715290 [TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA production for therapeutic applications. Lara AR; RamÃrez OT; Wunderlich M Methods Mol Biol; 2012; 824():271-303. PubMed ID: 22160904 [TBL] [Abstract][Full Text] [Related]
7. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography. Sousa F; Passarinha L; Queiroz JA Biotechnol Genet Eng Rev; 2010; 26():83-116. PubMed ID: 21415877 [TBL] [Abstract][Full Text] [Related]
8. Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms. Bo H; Wang J; Chen Q; Shen H; Wu F; Shao H; Huang S Pharm Biol; 2013 Jan; 51(1):42-8. PubMed ID: 23013372 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical grade large-scale plasmid DNA manufacturing process. Schmeer M; Schleef M Methods Mol Biol; 2014; 1143():219-40. PubMed ID: 24715291 [TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA for pharmaceutical applications. Schleef M; Schmidt T; Flaschel E Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820 [TBL] [Abstract][Full Text] [Related]
11. Current trends in separation of plasmid DNA vaccines: a review. Ghanem A; Healey R; Adly FG Anal Chim Acta; 2013 Jan; 760():1-15. PubMed ID: 23265728 [TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing. Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in chromatographic purification of plasmid DNA for gene therapy and DNA vaccines: A review. Abdulrahman A; Ghanem A Anal Chim Acta; 2018 Sep; 1025():41-57. PubMed ID: 29801607 [TBL] [Abstract][Full Text] [Related]
14. Purification of influenza deoxyribonucleic acid-based vaccine using agmatine monolith. Bicho D; Caramelo-Nunes C; Sousa A; Sousa F; Queiroz JA; Tomaz CT J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():153-61. PubMed ID: 26827278 [TBL] [Abstract][Full Text] [Related]
15. Engineering of bacterial strains and vectors for the production of plasmid DNA. Bower DM; Prather KL Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691 [TBL] [Abstract][Full Text] [Related]
16. Using Plasmids as DNA Vaccines for Infectious Diseases. Tregoning JS; Kinnear E Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104452 [TBL] [Abstract][Full Text] [Related]
17. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related]
18. Purification of plasmids for gene therapy and DNA vaccination. Prazeres DM; Monteiro GA; Ferreira GN; Diogo MM; Ribeiro SC; Cabral JM Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041 [TBL] [Abstract][Full Text] [Related]
19. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Ferreira GN; Monteiro GA; Prazeres DM; Cabral JM Trends Biotechnol; 2000 Sep; 18(9):380-8. PubMed ID: 10942962 [TBL] [Abstract][Full Text] [Related]
20. DNA vaccine manufacture: scale and quality. Cai Y; Rodriguez S; Hebel H Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]